Constance M. Yuan

14.7k total citations · 3 hit papers
121 papers, 5.9k citations indexed

About

Constance M. Yuan is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Constance M. Yuan has authored 121 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Oncology, 44 papers in Pathology and Forensic Medicine and 43 papers in Genetics. Recurrent topics in Constance M. Yuan's work include Lymphoma Diagnosis and Treatment (43 papers), Chronic Lymphocytic Leukemia Research (39 papers) and CAR-T cell therapy research (39 papers). Constance M. Yuan is often cited by papers focused on Lymphoma Diagnosis and Treatment (43 papers), Chronic Lymphocytic Leukemia Research (39 papers) and CAR-T cell therapy research (39 papers). Constance M. Yuan collaborates with scholars based in United States, United Kingdom and Egypt. Constance M. Yuan's co-authors include Maryalice Stetler‐Stevenson, Nirali N. Shah, Terry J. Fry, Alan S. Wayne, Cindy Delbrook, Rimas J. Orentas, Crystal L. Mackall, Seth M. Steinberg, James N. Kochenderfer and Ling Zhang and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Constance M. Yuan

115 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

2014 2.2k citations Daniel W Lee, James N. Kochenderfer et al. profile →
Anti-CD22–chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia

2012 440 citations Daniel W. Lee, Nirali N. Shah et al. Blood profile →
Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL

2021 200 citations Nirali N. Shah, Daniel W. Lee et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Constance M. Yuan

Since Specialization

Citations

This map shows the geographic impact of Constance M. Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Constance M. Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Constance M. Yuan more than expected).

Fields of papers citing papers by Constance M. Yuan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Constance M. Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Constance M. Yuan. The network helps show where Constance M. Yuan may publish in the future.

Co-authorship network of co-authors of Constance M. Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Constance M. Yuan. A scholar is included among the top collaborators of Constance M. Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Constance M. Yuan. Constance M. Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Harmonization on defining B‐cell recovery post CD19‐CAR T‐cell therapy in B‐cell acute lymphoblastic leukemia: An international consensus statement 2025 ·HemaSphere ·Adam J. Lamble, Sandra D. Bohling, Kara L. Davis, Aimee C. Talleur, Kevin O. McNerney, (unknown), Priya Kumar, Rebecca Thomas, Hao‐Wei Wang, Constance M. Yuan, Elad Jacoby, André Baruchel, Sara Ghorashian, Michael A. Pulsipher, Liora M. Schultz, Rebecca Gardner, Nirali N. Shah	0
2	A Decade of Ibrutinib for CLL with and without TP53 Aberration: Final Report on an Investigator-Sponsored Phase 2 Study 2025 ·Blood ·(unknown), (unknown), (unknown), Constance M. Yuan, Hao‐Wei Wang, Inhye E. Ahn, Mohammed Farooqui, Xin Tian, Clare Sun, (unknown), Susan Soto, Jeanine Superata, (unknown), Thomas E. Hughes, Pia Nierman, Adrian Wiestner	0
3	Ten-year experience of CD22 CAR T cells for children and young adults with B-cell acute lymphoblastic leukemia 2025 ·Blood Advances ·Alexandra Dreyzin, Bonnie Yates, Haneen Shalabi, Sara Silbert, Hao‐Wei Wang, Constance M. Yuan, (unknown), (unknown), (unknown), (unknown), (unknown), Lauren Little, Toni Foley, Véronique Nussenblatt, Terry J. Fry, David F. Stroncek, Steven L. Highfill, Nirali N. Shah	0
4	Phase 2 trial of rituximab with either pentostatin or bendamustine for multiply relapsed or refractory hairy cell leukemia 2025 ·Blood ·Brett Schroeder, Constance M. Yuan, Hao‐Wei Wang, (unknown), Hong Zhou, Mark Raffeld, Liqiang Xi, Evgeny Arons, (unknown), (unknown), Katherine R. Calvo, Irina Marić, Robert J. Kreitman	0
5	Treatment strategies for progressive immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome: case series 2024 ·Haematologica ·(unknown), Michael J. Eckrich, (unknown), Bonnie Yates, Constance M. Yuan, Hao‐Wei Wang, Saurabh Dahiya, Jan‐Inge Henter, Jeffrey S. Huo, Matthew J. Frank, Nirali N. Shah	8
6	COVID-19 in patients with classic and variant hairy cell leukemia 2023 ·Blood Advances ·Robert J. Kreitman, (unknown), (unknown), (unknown), (unknown), (unknown), M N Gould, (unknown), Hong Zhou, Peter D. Burbelo, Jeffrey I. Cohen, Hao‐Wei Wang, Constance M. Yuan, Evgeny Arons	2
7	Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell Failure 2023 ·Transplantation and Cellular Therapy ·(unknown), Bonnie Yates, Seth M. Steinberg, Constance M. Yuan, Hao‐Wei Wang, Colleen Annesley, Haneen Shalabi, David F. Stroncek, Terry J. Fry, Joerg Krueger, Elad Jacoby, Emily M. Hsieh, Deepa Bhojwani, Rebecca Gardner, Shannon L. Maude, Nirali N. Shah	4
8	Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulation 2022 ·Journal for ImmunoTherapy of Cancer ·(unknown), John C. Molina, (unknown), (unknown), Ting Zhou, Constance M. Yuan, Hao‐Wei Wang, Maryalice Stetler‐Stevenson, Crystal L. Mackall, Terry J. Fry, Sandhya R. Panch, Steven L. Highfill, David F. Stroncek, Lauren Little, Daniel W Lee, Haneen Shalabi, Bonnie Yates, Nirali N. Shah	31
9	Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy 2021 ·Blood Advances ·(unknown), Bonnie Yates, Alexander Ling, Constance M. Yuan, Hao‐Wei Wang, Maryalice Stetler‐Stevenson, (unknown), John C. Molina, Daniel A. Lichtenstein, Daniel W. Lee, John A. Ligon, Haneen Shalabi, Mark A. Ahlman, Nirali N. Shah	35
10	Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL breakdown → 2021 ·Journal of Clinical Oncology ·Nirali N. Shah, Daniel W. Lee, Bonnie Yates, Constance M. Yuan, Haneen Shalabi, Staci Martin, Pamela L. Wolters, Seth M. Steinberg, Eva H. Baker, Cindy Delbrook, Maryalice Stetler‐Stevenson, Terry J. Fry, David F. Stroncek, Crystal L. Mackall	200
11	Modulation of Target Antigen Density Improves CAR T-cell Functionality and Persistence 2019 ·Clinical Cancer Research ·Sneha Ramakrishna, Steven L. Highfill, (unknown), Sang M. Nguyen, Haiyan Lei, Jack F. Shern, Haiying Qin, Ira L. Kraft, Maryalice Stetler‐Stevenson, Constance M. Yuan, Jennifer Hwang, Yang Feng, Zhongyu Zhu, Dimiter S. Dimitrov, Nirali N. Shah, Terry J. Fry	115
12	Tumor-Derived GM-CSF Promotes Granulocyte Immunosuppression in Mesothelioma Patients 2018 ·Clinical Cancer Research ·Swati Khanna, (unknown), Francis Mussai, Anish Thomas, Neha Wali, (unknown), Constance M. Yuan, Betsy Morrow, Jingli Zhang, Firouzeh Korangy, Tim F. Greten, Seth M. Steinberg, Maryalice Stetler‐Stevenson, Gary Middleton, Carmela De Santo, Raffit Hassan	43
13	Activation of Th1 Immunity within the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia 2018 ·The Journal of Immunology ·Georg Aue, Clare Sun, Delong Liu, Jae‐Hyun Park, Stefania Pittaluga, Xin Tian, Elinor Lee, Susan Soto, Janet Valdez, Irina Marić, Maryalice Stetler‐Stevenson, Constance M. Yuan, Yusuke Nakamura, Pawel Muranski, Adrian Wiestner	21
14	Quantification of B-cell maturation antigen, a target for novel chimeric antigen receptor T-cell therapy in Myeloma 2018 ·Leukemia Research ·Dalia Salem, Irina Marić, Constance M. Yuan, David J. Liewehr, David Venzon, James N. Kochenderfer, Maryalice Stetler‐Stevenson	33
15	Long-Term Outcomes Following CD19 CAR T Cell Therapy for B-ALL Are Superior in Patients Receiving a Fludarabine/Cyclophosphamide Preparative Regimen and Post-CAR Hematopoietic Stem Cell Transplantation 2016 ·Blood ·Daniel W. Lee, Maryalice Stetler‐Stevenson, Constance M. Yuan, Nirali N. Shah, Cindy Delbrook, Bonnie Yates, Hua Zhang, Ling Zhang, James N. Kochenderfer, Steven A. Rosenberg, Terry J. Fry, David Stroncek, Crystal L. Mackall	90
16	Disruption of in vivo Chronic Lymphocytic Leukemia Tumor–Microenvironment Interactions by Ibrutinib – Findings from an Investigator-Initiated Phase II Study 2015 ·Clinical Cancer Research ·Carsten Utoft Niemann, Sarah E. M. Herman, Irina Marić, Julio Gómez‐Rodríguez, Angélique Biancotto, Betty Chang, Sabrina Martyr, Maryalice Stetler‐Stevenson, Constance M. Yuan, Katherine R. Calvo, Raul C. Braylan, Janet Valdez, Yuh Shan Lee, Deanna H. Wong, Jade Jones, Clare Sun, Gerald E. Marti, Mohammed Farooqui, Adrian Wiestner	160
17	Interactions between Ibrutinib and Anti-CD20 Antibodies: Competing Effects on the Outcome of Combination Therapy 2015 ·Clinical Cancer Research ·Martin Skarzynski, Carsten Utoft Niemann, Yuh Shan Lee, Sabrina Martyr, Irina Marić, Dalia Salem, Maryalice Stetler‐Stevenson, Gerald E. Marti, Katherine R. Calvo, Constance M. Yuan, Janet Valdez, Susan Soto, Mohammed Farooqui, Sarah E. M. Herman, Adrian Wiestner	62
18	Distinguishing hairy cell leukemia variant from hairy cell leukemia: Development and validation of diagnostic criteria 2013 ·Leukemia Research ·Haipeng Shao, Katherine R. Calvo, (unknown), Prashant Tembhare, Robert J. Kreitman, Maryalice Stetler‐Stevenson, Constance M. Yuan	81
19	Molecular and biologic markers of progression in monoclonal gammopathy of undetermined significance to multiple myeloma 2010 ·Leukemia & lymphoma ·Sham Mailankody, Esther Mena, Constance M. Yuan, Arun Balakumaran, W. Michael Kuehl, Ola Landgren	19
20	PRAME expression in hairy cell leukemia 2008 ·Leukemia Research ·Evgeny Arons, (unknown), Inger Margulies, Constance M. Yuan, Maryalice Stetler‐Stevenson, Robert J. Kreitman	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact